0001493152-22-018605.txt : 20220705
0001493152-22-018605.hdr.sgml : 20220705
20220705195508
ACCESSION NUMBER: 0001493152-22-018605
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220701
FILED AS OF DATE: 20220705
DATE AS OF CHANGE: 20220705
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Barr Jason Michael
CENTRAL INDEX KEY: 0001645550
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21617
FILM NUMBER: 221067062
MAIL ADDRESS:
STREET 1: 902 BROADWAY, 15TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ProPhase Labs, Inc.
CENTRAL INDEX KEY: 0000868278
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 232577138
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 711 STEWART AVE, SUITE 200
STREET 2: GARDEN CITY
CITY: NEW YORK
STATE: NY
ZIP: 11530
BUSINESS PHONE: (215) 345-0919
MAIL ADDRESS:
STREET 1: 711 STEWART AVE, SUITE 200
STREET 2: GARDEN CITY
CITY: NEW YORK
STATE: NY
ZIP: 11530
FORMER COMPANY:
FORMER CONFORMED NAME: QUIGLEY CORP
DATE OF NAME CHANGE: 19930328
4
1
ownership.xml
X0306
4
2022-07-01
0
0000868278
ProPhase Labs, Inc.
PRPH
0001645550
Barr Jason Michael
711 STEWART AVENUE,
SUITE 200
GARDEN CITY,
NY
11530
1
0
0
0
Option (right to buy)
12.92
2022-07-01
4
A
0
40000
0
A
2029-07-01
Common Stock
40000
40000
D
The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock, with such option vesting in four equal quarterly installments over one year, with the first quarterly installment to vest on September 30, 2022 and each additional installment to vest quarterly thereafter, provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of July 1, 2022.
/s/ Jason Barr
2022-07-05